About us – IMMUMEDIC Limited
Competence Center for Modern Immunotherapy & Integrative Oncology
IMMUMEDIC Limited is a Europe-wide center of excellence for immunological therapy concepts, therapy support and scientifically based patient education.
Our focus is on dendritic cell therapy, complementary immunotherapies and innovative strategies in biological cancer medicine.
In collaboration with specialized laboratories, clinics, doctors and international research institutes, we support patients in finding their way in the complex field of modern immunotherapies and in making well-founded individual therapy decisions.
Our focus areas
individual immunotherapy planning
e.g. dendritic cell therapy, T-cell activation, tumor-directed immune strategiesTherapy support & aftercare advice
structured, patient-centered and internationally networkedAccess to specialized centers and research partners
Europe-wide and worldwideMedical Education & Patient Education
about the opportunities, limitations and scientific basis of modern immune proceduresParticipation in research & publications
for the further development of immunological therapies
Vision & Values
We believe that modern cancer treatment must do more than destroy tumor tissue.
She must:
strengthen instead of weakening,
precise rather than unspecific
and act in a biologically integrated way rather than in isolation.
The focus is always on the immune system as the key to cancer medicine.
Our values:
Transparency & reliable information
Individualized medical concepts
scientifically validated principles
International networking & innovative perspectives
Our commitment
IMMUMEDIC is actively working to strengthen the bridge between medical progress and individual patient access.
This includes:
Specialist publications and medical knowledge transfer
Development of digital information formats for affected individuals
Building international cooperation networks between doctors, laboratories, clinics and researchers
Andreas Rach, founder and managing director of IMMUMEDIC Limited, has been working in the field of integrative oncology and immunological therapies for over 10 years.
His focus is on the question of how the immune system can be specifically strengthened and made therapeutically usable – scientifically sound, patient-oriented and internationally oriented.
With the book project
“Dendritic cell therapy – Immunological cancer therapy of the future”
He advocates for understandable, reputable and well-prepared patient education.
IMMUMEDIC thus stands for a modern, responsible and innovative form of support for immunological cancer therapies.